Search Results

There are 26166 results for: content related to: Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer

  1. You have free access to this content
    Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?

    BJU International

    Volume 108, Issue 10, November 2011, Pages: 1588–1596, Murray Krahn, Karen E. Bremner, George Tomlinson, Jin Luo, Paul Ritvo, Gary Naglie and Shabbir M.H. Alibhai

    Version of Record online : 31 MAR 2011, DOI: 10.1111/j.1464-410X.2011.10127.x

  2. You have free access to this content
    Concept and viability of androgen annihilation for advanced prostate cancer

    Cancer

    Volume 120, Issue 17, September 1, 2014, Pages: 2628–2637, James L. Mohler

    Version of Record online : 25 APR 2014, DOI: 10.1002/cncr.28675

  3. You have free access to this content
    Metabolic changes in patients with prostate cancer during androgen deprivation therapy

    International Journal of Urology

    Koji Mitsuzuka and Yoichi Arai

    Version of Record online : 20 OCT 2017, DOI: 10.1111/iju.13473

  4. You have free access to this content
    Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer

    BJU International

    Volume 96, Issue 4, September 2005, Pages: 503–507, Daniel M. Janoff, Chad Peterson, Solange Mongoue-Tchokote, Laura Peters, Tomasz M. Beer, Emily M. Wersinger, Motomi Mori and Mark Garzotto

    Version of Record online : 11 AUG 2005, DOI: 10.1111/j.1464-410X.2005.05674.x

  5. You have free access to this content
    Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology

    CA: A Cancer Journal for Clinicians

    Volume 60, Issue 3, May/June 2010, Pages: 194–201, Glenn N. Levine, Anthony V. D'Amico, Peter Berger, Peter E. Clark, Robert H. Eckel, Nancy L. Keating, Richard V. Milani, Arthur I. Sagalowsky, Matthew R. Smith and Neil Zakai

    Version of Record online : 3 FEB 2010, DOI: 10.3322/caac.20061

  6. Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects

    The Journal of Sexual Medicine

    Volume 9, Issue 3, March 2012, Pages: 887–902, Giovanni Corona, Mauro Gacci, Elisabetta Baldi, Rosa Mancina, Gianni Forti and Mario Maggi

    Version of Record online : 16 JAN 2012, DOI: 10.1111/j.1743-6109.2011.02590.x

  7. Androgen deprivation therapy's impact on the mood of prostate cancer patients as perceived by patients and the partners of patients

    Psycho-Oncology

    Volume 25, Issue 7, July 2016, Pages: 848–856, Dexter Van Dam, Richard J. Wassersug and Lisa Dawn Hamilton

    Version of Record online : 31 AUG 2015, DOI: 10.1002/pon.3932

  8. Simple algebraic data types for C

    Software: Practice and Experience

    Volume 42, Issue 2, February 2012, Pages: 191–210, Pieter H. Hartel and Henk L. Muller

    Version of Record online : 11 FEB 2011, DOI: 10.1002/spe.1058

  9. Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life

    The Journal of Sexual Medicine

    Volume 7, Issue 9, September 2010, Pages: 2996–3010, Stacy Elliott, David M. Latini, Lauren M. Walker, Richard Wassersug, John W. Robinson and the ADT Survivorship Working Group

    Version of Record online : 7 JUL 2010, DOI: 10.1111/j.1743-6109.2010.01902.x

  10. You have free access to this content
    Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners

    Cancer

    Volume 121, Issue 24, December 15, 2015, Pages: 4286–4299, Kristine A. Donovan, Lauren M. Walker, Richard J. Wassersug, Lora M. A. Thompson and John W. Robinson

    Version of Record online : 15 SEP 2015, DOI: 10.1002/cncr.29672

  11. You have free access to this content
    Androgen Deprivation Therapy, Insulin Resistance, and Cardiovascular Mortality: An Inconvenient Truth

    Journal of Andrology

    Volume 29, Issue 5, September-October 2008, Pages: 534–539, Shehzad Basaria

    Version of Record online : 2 JAN 2013, DOI: 10.2164/jandrol.108.005454

  12. You have free access to this content
    Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer

    BJU International

    Volume 120, Issue S3, November 2017, Pages: 35–42, Wee Loon Ong, Farshad Foroudi, Sue Evans and Jeremy Millar

    Version of Record online : 19 AUG 2017, DOI: 10.1111/bju.13969

  13. Androgen Deprivation Therapy Impact on Quality of Life and Cardiovascular Health, Monitoring Therapeutic Replacement

    The Journal of Sexual Medicine

    Volume 10, Issue S1, February 2013, Pages: 84–101, Landon W. Trost, Ege Serefoglu, Ahmet Gokce, Brian J. Linder, Alton O. Sartor and Wayne J.G. Hellstrom

    Version of Record online : 6 FEB 2013, DOI: 10.1111/jsm.12036

  14. You have free access to this content
    A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

    BJU International

    Volume 107, Issue 6, March 2011, Pages: 924–928, Howard S. Kim, Daniel M. Moreira, Matthew R. Smith, Joseph C. Presti Jr, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling and Stephen J. Freedland

    Version of Record online : 22 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09679.x

  15. You have free access to this content
    Androgen deprivation therapy: past, present and future

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 1–12, F. Schröder, E.D. Crawford, K. Axcrona, H. Payne and T.E. Keane

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11215.x

  16. You have free access to this content
    Androgen deprivation and thromboembolic events in men with prostate cancer

    Cancer

    Volume 118, Issue 13, 1 July 2012, Pages: 3397–3406, Behfar Ehdaie, Coral L. Atoria, Amit Gupta, Andrew Feifer, William T. Lowrance, Michael J. Morris, Peter T. Scardino, James A. Eastham and Elena B. Elkin

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26623

  17. You have free access to this content
    Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison

    Psycho-Oncology

    Volume 24, Issue 4, April 2015, Pages: 472–477, Morgan Lee, Heather S. Jim, Mayer Fishman, Babu Zachariah, Randy Heysek, Matthew Biagioli and Paul B. Jacobsen

    Version of Record online : 13 JUN 2014, DOI: 10.1002/pon.3608

  18. You have full text access to this OnlineOpen article
    Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer

    International Journal of Clinical Practice

    Volume 69, Issue 1, January 2015, Pages: 106–123, I. D. White, J. Wilson, P. Aslet, A. B. Baxter, A. Birtle, B. Challacombe, J. Coe, L. Grover, H. Payne, S. Russell, V. Sangar, N. Van As and M. Kirby

    Version of Record online : 5 OCT 2014, DOI: 10.1111/ijcp.12512

  19. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison

    Psycho-Oncology

    Kristine A. Donovan, Brian D. Gonzalez, Ashley M. Nelson, Mayer N. Fishman, Babu Zachariah and Paul B. Jacobsen

    Version of Record online : 27 JUN 2017, DOI: 10.1002/pon.4463

  20. You have free access to this content
    Information needs of men on androgen deprivation therapy

    BJU International

    Volume 109, Issue 10, May 2012, Pages: 1503–1509, Tony Soeyonggo, Padraig Warde, Neil Fleshner, Narhari Timilshina and Shabbir M.H. Alibhai

    Version of Record online : 24 AUG 2011, DOI: 10.1111/j.1464-410X.2011.10475.x